Angiosarcoma

2 trials 2 recruiting MedDRA PT
2 Registered trials
2 Recruiting
2 Unique sponsors
2 Unique IMPs
0 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Checkpoint inhibitor (PD-1) 1 substance
Unknown / small molecule 1 substance
Phase III: 1 Phase II: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Universitaet Muenster Academic
    TTF-NGR
    2024-516392-33-00 1 country 2021 n=126
    Recruiting

Phase II

1 trial
  • Region Hovedstaden Academic
    PEMBROLIZUMAB
    2024-513727-16-00 3 countries 2022 n=100
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Region Hovedstaden Academic 1 Phase II 1
Universitaet Muenster Academic 1 Phase III 1
New trials by year
2021
1
2022
1
← All indication landscapes